Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2025 Jun 20:16:1586945.
doi: 10.3389/fpsyt.2025.1586945. eCollection 2025.

Ketamine treatment for buprenorphine-precipitated opioid withdrawal: a case report

Ezioma Gbujie  1   2   3 , Lisa Vercollone  3 , Joji Suzuki  1   2
Affiliations
Case Reports

Ketamine treatment for buprenorphine-precipitated opioid withdrawal: a case report

Ezioma Gbujie et al. Front Psychiatry. .

Abstract

Background: The presence of fentanyl in the drug supply is thought to contribute to the incidence of buprenorphine-precipitated opioid withdrawal (BPOW) during initiation. Long used as a surgical anesthetic and an analgesic, the utility of ketamine for psychiatric and substance use disorder indications continues to grow. We present a case of intravenous (IV) ketamine use on the general medical floor for the management of BPOW in a hospitalized patient.

Case summary: A 72-year-old male presented to the emergency room with new-onset hematuria and was admitted for urological intervention. Hematuria was successfully managed with continuous bladder irrigation over 3 days. Unfortunately, on hospital day two, the patient developed myalgias, restlessness, and later revealed ongoing non-medical use of illicit opioids. The addiction consultation service was consulted on the second day of hospitalization and made a new diagnosis of severe opioid use disorder. Two separate attempts at buprenorphine/naloxone high-dose initiation to treat BPOW were not successful and the second was not responsive to standard symptomatic agents. An IV ketamine 27mg bolus was then administered, with an initial improvement followed by subsequent emergence delirium, which was addressed with IV haloperidol. The patient was eventually stabilized on buprenorphine/naloxone 8mg twice daily prior to discharge.

Clinical significance: Ketamine may be an effective adjunctive agent in managing opioid withdrawal. Usually restricted to the intensive care unit and emergency department, this case report highlights both the potential and risks of IV ketamine on the general hospital floors. Further research is needed to better understand the safety of using ketamine to manage opioid withdrawal.

Keywords: buprenorphine; buprenorphine initiation; buprenorphine opioid withdrawal; fentanyl; ketamine.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Withdrawal-MAR timeline.
See this image and copyright information in PMC

References

    1. Silverstein SM, Daniulaityte R, Martins SS, Miller SC, Carlson RG. Everything is not right anymore”: Buprenorphine experiences in an era of illicit fentanyl. Int J Drug Policy. (2019) 74:76–83. doi: 10.1016/j.drugpo.2019.09.003 - DOI - PMC - PubMed
    1. Walsh S. The clinical pharmacology of buprenorphine: extrapolating from the laboratory to the clinic. Drug Alcohol Depend. (2003) 70:S13–27. doi: 10.1016/s0376-8716(03)00056-5 - DOI - PubMed
    1. Hailozian C, Luftig J, Liang A, Outhay M, Ullal M, Anderson ES, et al. Synergistic effect of ketamine and buprenorphine observed in the treatment of buprenorphine precipitated opioid withdrawal in a patient with fentanyl use. J Addict Med. (2021) 16(4):483–7. doi: 10.1097/adm.0000000000000929 - DOI - PubMed
    1. Oakley B, Wilson H, Hayes V, Lintzeris N. Managing opioid withdrawal precipitated by buprenorphine with buprenorphine. Drug Alcohol Rev. (2021) 40(4):567–71. doi: 10.1111/dar.13228 - DOI - PMC - PubMed
    1. Gregory C, Yadav K, Linders J, Sikora L, Eagles D. Incidence of buprenorphine-precipitated opioid withdrawal in adults with opioid use disorder: A systematic review. Addiction. (2024) 120:7–20. doi: 10.1111/add.16646 - DOI - PubMed

Publication types

LinkOut - more resources